المؤلفون: Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., Kummel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., Harbeck, N., Takahashi, M., Untch, M., Fasching, P. A., Cardoso, F., Andersen, J., Patt, D., Danso, M., Ferreira, M., Mouret-Reynier, M-A, Im, S-A, Ahn, J-H, Gion, M., Baron-Hay, S., Boileau, J-F, Ding, Y., Tryfonidis, K., Aktan, G., Karantza, V, O'Shaughnessy, J.

المساهمون: 임석아, Im, S-A

مصطلحات موضوعية: CLINICAL-FEATURES, PLUS CHEMOTHERAPY, PRIMARY THERAPY, ADVERSE EVENTS

العلاقة: New England Journal of Medicine, Vol.386 No.6, pp.556-567; 155307; https://hdl.handle.net/10371/179237Test; 000753100900011; 2-s2.0-85124776620

الإتاحة: https://doi.org/10.1056/NEJMoa2112651Test
https://hdl.handle.net/10371/179237Test

المؤلفون: Cortes, J., Kim, S.-B., Chung, W.-P., Im, S.-A., Park, Y.H., Hegg, R., Kim, M.H., Tseng, L.-M., Petry, V., Chung, C.-F., Iwata, H., Hamilton, E., Curigliano, G., Xu, B., Huang, C.-S., Kim, J.H., Chiu, J.W.Y., Pedrini, J.L., Lee, C., Liu, Y., Cathcart, J., Bako, E., Verma, S., Hurvitz, S.A.

المساهمون: 임석아, Im, S.-A.

مصطلحات موضوعية: ANTIBODY-DRUG CONJUGATE, LUNG-DISEASE ILD, DS-8201A, PERTUZUMAB, DOCETAXEL

العلاقة: New England Journal of Medicine, Vol.386 No.12, pp.1142-1154; 158583; https://hdl.handle.net/10371/179230Test; 000928461300009; 2-s2.0-85127402448

الإتاحة: https://doi.org/10.1056/NEJMoa2115022Test
https://hdl.handle.net/10371/179230Test

المؤلفون: Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De, Laurentiis M., Im, S., Petrakova, K., Valeria, Bianchi G., Martin, M., Nusch, A., Sonke, G.S., De, la Cruz-Merino L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.

المساهمون: Im, S.

العلاقة: Annals of Oncology, Vol.32 No.10, pp.1307-1307; https://hdl.handle.net/10371/189537Test; 000709095000017; 2-s2.0-85112792663; 158588

الإتاحة: https://doi.org/10.1016/j.annonc.2021.07.011Test
https://hdl.handle.net/10371/189537Test

المؤلفون: Gennari, A., Andre, F., Barrios, C. H., Cortes, J., de Azambuja, E., DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S. A., Im, S. -a., Krug, D., Kunz, W. G., Loi, S., Penault-Llorca, F., Ricke, J., Robson, M., Rugo, H. S., Saura, C., Schmid, P., Singer, C. F., Spanic, T., Tolaney, S. M., Turner, N. C., Curigliano, G., Loibl, S., Paluch-Shimon, S., Harbeck, N., ESMO Guidelines Committee

المساهمون: 임석아, Im, S. -a.

مصطلحات موضوعية: INTERNATIONAL CONSENSUS GUIDELINES, ALPELISIB PLUS FULVESTRANT, GERMLINE BRCA MUTATION, DOUBLE-BLIND, OPEN-LABEL, PHYSICIANS CHOICE, SACITUZUMAB GOVITECAN, TRASTUZUMAB EMTANSINE, REPORTED OUTCOMES, ENDOCRINE THERAPY, diagnosis, ESCAT, ESMO Clinical Practice Guideline, ESMO-MCBS, metastatic breast cancer, treatment

العلاقة: Annals of Oncology, Vol.32 No.12, pp.1475-1495; 153495; https://hdl.handle.net/10371/179242Test; 000721610600008; 2-s2.0-85120812833

الإتاحة: https://doi.org/10.1016/j.annonc.2021.09.019Test
https://hdl.handle.net/10371/179242Test

المؤلفون: Ke, L.D., Fueyo, J., Chen, X., Steck, P.A., Shi, Y.-X., Im, S.-A., Yung, W.K.A.

المساهمون: 임석아, Im, S.-A.

مصطلحات موضوعية: Gene therapy, Glioma, Ribozymes, Vascular endothelial growth factor

العلاقة: International Journal of Oncology, Vol.12 No.6, pp.1391-1396; 158753; https://hdl.handle.net/10371/179222Test; 000073815500029; 2-s2.0-0042966942

الإتاحة: https://doi.org/10.3892/ijo.12.6.1391Test
https://hdl.handle.net/10371/179222Test

المؤلفون: Song, S., Chie, E.K., Kim, K., Lee, H.-J., Yang, H.-K., Han, S.-W., Oh, D.-Y., Im, S.-A., Bang, Y.-J., Ha, S.W.

المساهمون: 임석아, Chie, E.K., Lee, H.-J., Yang, H.-K., Oh, D.-Y., Im, S.-A., Bang, Y.-J.

مصطلحات موضوعية: Adjuvant chemoradiotherapy, Local, Neoplasm recurrence, Stomach neoplasm

العلاقة: Radiation Oncology Journal, Vol.30 No.4, pp.213-217; 158773; https://hdl.handle.net/10371/179210Test; 2-s2.0-84872475138; ART001725242

الإتاحة: https://doi.org/10.3857/roj.2012.30.4.213Test
https://hdl.handle.net/10371/179210Test

المؤلفون: Im, S.-A., Gomez-Manzano, C., Fueyo, J., Liu, T.-J., Ke, L.D., Kim, J.-S., Lee, H.-Y., Steck, P.A., Kyritsis, A.P., Yung, W.K.A.

المساهمون: 임석아, Im, S.-A.

العلاقة: Cancer Research, Vol.59 No.4, pp.895-900; 158754; https://hdl.handle.net/10371/179221Test; 000078617700023; 2-s2.0-0033557535

الإتاحة: https://hdl.handle.net/10371/179221Test

المؤلفون: Ke, L.D., Shi, Y.-X., Im, S.-A., Chen, X., Yung, W.K.A.

المساهمون: 임석아, Im, S.-A.

العلاقة: Clinical Cancer Research, Vol.6 No.6, pp.2562-2572; 158759; https://hdl.handle.net/10371/179220Test; 000087540300055; 2-s2.0-0041349558

الإتاحة: https://hdl.handle.net/10371/179220Test

المؤلفون: Slamon, D. J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Cruz Merino, Luis de la, Fasching, P. A.

المساهمون: Universidad de Sevilla. Departamento de Medicina

مصطلحات موضوعية: CDK4/6 inhibitor, Advanced breast cancer, Overall survival, Ribociclib

العلاقة: Annals of Oncology, 32 (8), 1015-1024.; https://www.sciencedirect.com/science/article/pii/S0923753421015532?via%3DihubTest; https://idus.us.es/handle//11441/139712Test

الإتاحة: https://idus.us.es/handle//11441/139712Test

المؤلفون: Rugo, HS, Im, S-A, Joy, AA, Shparyk, Y, Walshe, JM, Sleckman, B, Loi, S, Theall, KP, Kim, S, Huang, X, Bananis, E, Mahtani, R, Finn, RS, Dieras, V

العلاقة: pii: S0960-9776(22)00188-6; Rugo, H. S., Im, S. -A., Joy, A. A., Shparyk, Y., Walshe, J. M., Sleckman, B., Loi, S., Theall, K. P., Kim, S., Huang, X., Bananis, E., Mahtani, R., Finn, R. S. & Dieras, V. (2022). Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3. BREAST, 66, pp.324-331. https://doi.org/10.1016/j.breast.2022.11.005Test.; http://hdl.handle.net/11343/335416Test

الإتاحة: https://doi.org/10.1016/j.breast.2022.11.005Test
http://hdl.handle.net/11343/335416Test